TipRanks
Advertisement
Advertisement
Tarsus Pharmaceuticals reinstated with an Overweight at Barclays
PremiumThe FlyTarsus Pharmaceuticals reinstated with an Overweight at Barclays
1M ago
Tarsus Pharmaceuticals Completes Alkeus Retinal Therapy Acquisition
Premium
Company Announcements
Tarsus Pharmaceuticals Completes Alkeus Retinal Therapy Acquisition
1M ago
Tarsus Pharmaceuticals price target raised to $105 from $88 at Jefferies
Premium
The Fly
Tarsus Pharmaceuticals price target raised to $105 from $88 at Jefferies
1M ago
Analyst Reiterates Buy on Tarsus, Citing Strong XDEMVY Momentum, Ophthalmology Pipeline Expansion, and Unchanged $88 Price Target
PremiumRatingsAnalyst Reiterates Buy on Tarsus, Citing Strong XDEMVY Momentum, Ophthalmology Pipeline Expansion, and Unchanged $88 Price Target
3M ago
Tarsus Pharmaceuticals Balances XDEMVY Surge With Retina Bet
Premium
Company Announcements
Tarsus Pharmaceuticals Balances XDEMVY Surge With Retina Bet
3M ago
Tarsus to acquire Alkeus Pharmaceuticals for $450M upfront, up to $800M total
Premium
The Fly
Tarsus to acquire Alkeus Pharmaceuticals for $450M upfront, up to $800M total
3M ago
Tarsus Pharmaceuticals price target lowered to $98 from $100 at Mizuho
PremiumThe FlyTarsus Pharmaceuticals price target lowered to $98 from $100 at Mizuho
3M ago
Tarsus Pharmaceuticals price target lowered to $98 from $100 at Mizuho
Premium
The Fly
Tarsus Pharmaceuticals price target lowered to $98 from $100 at Mizuho
3M ago
Tarsus Pharmaceuticals price target lowered to $89 from $90 at Guggenheim
Premium
The Fly
Tarsus Pharmaceuticals price target lowered to $89 from $90 at Guggenheim
3M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―